Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

KRT17 (Keratin 17)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

DecisionDx® DiffDx-Melanoma

DecisionDx® DiffDx-Melanoma

›

KRT17 overexpression	Squamous Cell Carcinoma of Head and Neck	KRT17 overexpression	Squamous Cell Carcinoma of Head and Neck	pembrolizumab Resistant: C3 – Early Trials pembrolizumab Resistant : C3	pembrolizumab Resistant: C3 – Early Trials pembrolizumab Resistant : C3
KRT17 underexpression	Breast Cancer	KRT17 underexpression	Breast Cancer	ribociclib Sensitive: D – Preclinical ribociclib Sensitive : D	ribociclib Sensitive: D – Preclinical ribociclib Sensitive : D
KRT17 overexpression	Squamous Cell Carcinoma of Head and Neck	KRT17 overexpression	Squamous Cell Carcinoma of Head and Neck	Immunotherapy Resistant: D – Preclinical Immunotherapy Resistant : D	Immunotherapy Resistant: D – Preclinical Immunotherapy Resistant : D